Germantown's Precigen raises $75M to advance treatments for rare diseases

The clinical-stage company is developing gene and cell therapies for cancers, autoimmune disorders and infectious diseases.

Source: bizjournals.com Health Care News Headlines - January 30, 2023 Category: Health Management Authors: Sara Gilgore Source Type: news